Addus Homecare's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Addus Homecare's ROA in the second quarter of 2026?
Addus Homecare Corp achieved a return on average assets (ROA) of 7.37 % in its second quarter of 2026, this is above ADUS's average return on assets of 6.19%.
Addus Homecare Corp assets over the 12 months ending in its second quarter of 2026 are valued at $1,428 million

ROA has improved compared to 7.04% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 124 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 897, from total ROA ranking in the first quarter of 2026 at 1071.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	3.45 %	-0.92 %	1.43 %	28.11 %	31.11 %
Y / Y Net Income Change	25.19 %	18.09 %	52.52 %	13.32 %	21.98 %
Net Income (TTM) in million	105	100	96	86	83
Return On Assets (TTM)	7.37 %	7.04 %	6.76 %	6.06 %	6.21 %
ADUS's Total Ranking	# 897	# 1071	# 1020	# 999	# 997
Total Assets (TTM) in million	1,458	1,395	1,437	1,423	1,409
Seq. Total Assets Change	4.51 %	-2.96 %	1.01 %	0.99 %	0.1 %
Seq. Net Income Change	10.12 %	-15.82 %	30.35 %	3.61 %	3.88 %

ADUS's 5 Years Annual ROA >> Back to ADUS Management Effectiveness >> Compare ADUS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 14
Sector	# 125
Overall	# 852

Return On Assets Statistics
High	Average	Low
14.36 %	6.19 %	3.5 %
(Sep 30 2013)		(Sep 30 2016)

Financial Statements
Addus Homecare's Assets	$ 1,458 million	ADUS's Balance sheet
Addus Homecare's Income	$ 28 million	Quarterly ADUS's Income Statement
ADUS's Income by Division		See ADUS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	2.07 %	39.46 %	8.9 %	-1.37 %	16.57 %
Total Assets in million	1,394	1,365	979	899	912
Y / Y Net Income Change	30.32 %	17.73 %	35.83 %	1.99 %	36.2 %
Net Income in million	96	74	63	46	45
Annual Return On Assets	6.88 %	5.39 %	6.39 %	5.12 %	4.95 %

ADUS's 5 Years Annual ROA >> Back to ADUS Management Effectiveness >> Compare ADUS ROA to its Competitors

Comment on ADUS's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 6.88 % compared to prior year, due to annual net income growth of 30.32 % to $95.91 million, while value of Addus Homecare's overall assets grew just by 2.07 % to $1,393.60 million, compared to $1,393.60 a year before.

More Return On Assets Ratios
ADUS's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ADUS's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ADUS's Competitors
Subscribers only: Roa for Addus Homecare's Suppliers
Subscribers only: Return On Assets for ADUS's Customers

You may also want to know
ADUS's Roi	ADUS's Inventory Turnover Ratio	ADUS's Growth Rates	ADUS's Dividend Comparisons
	ADUS's Profitability Ratios	ADUS's Asset Turnover Ratio	ADUS's Dividend Growth
ADUS's Roe	ADUS's Valuation Ratios	ADUS's Financial Strength Ratios	ADUS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %

Date modified: 2026-09-08T15:45:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.